Mucous Membrane Decontamination Market Size

  • Report ID: 4189
  • Published Date: Jul 26, 2024
  • Report Format: PDF, PPT

Mucous Membrane Decontamination Market Size

Mucous Membrane Decontamination Market size was over USD 8.08 Billion in 2023 and is anticipated to exceed USD 52 Billion by the end of 2036, growing at over 15.4% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of mucous membrane decontamination is evaluated at USD 9.2 Billion. The growth of the market can be attributed to the higher prevalence of healthcare-associated infection in hospitals backed by the growing regulations of keeping hygiene in hospitals.  According to the data published by the National Library of Medicine, it was noticed that nearly 1.7 million patients in hospital facilities get healthcare-associated infections (HCAIs) annually while around 98,000 of them die as a result of these infections, which is 1 in 17 patients across the globe.

The mucous membrane is the inner lining of particular organs that is often moist and found in the nose, stomach, mouth, and lungs. Mucous membrane decontamination is the procedure of decrement of the physiological flora along with pathogens. Furthermore, the global mucous membrane decontamination market is estimated to flourish on the back of a higher number of infections associated with wounds that require treatment to prevent severe symptoms where surgeries are mandated to treat the infectious wound. For instance, about 32% of surgical site infections were observed in patients in the year 2019. Additionally, the increasing inclination toward infection prevention and control is further projected to enlarge the market size over the forecast period. Hence, all these factors are expected to influence the growth of the market positively during the forecast period.


Mucous-Membrane-Decontamination-Market
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4189
  • Published Date: Jul 26, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of mucous membrane decontamination is evaluated at USD 9.2 Billion.

The mucous membrane decontamination market size was over USD 8.08 Billion in 2023 and is anticipated to exceed USD 52 Billion by the end of 2036, growing at over 15.4% CAGR during the forecast period i.e., between 2024-2036. Increasing inclination of global population toward personal hygiene and higher prevalence of post-surgical wound infection are the major factors driving the market growth.

North America is poised to account for majority industry share by 2036, attributed to higher prevalence of autoimmune diseases driven by presence of a developed healthcare infrastructure and growing inclination of people and clinicians toward the utilization of novel drugs.

Astellas Pharma Inc., Bausch Health Companies Inc., Genentech, Inc., Lipidor AB, Pfizer Inc., Merck & Co., Inc., Sun Pharmaceutical Industries Limited, EPI Health, LLC, Mölnlycke Health Care AB, Reckitt Benckiser Group plc
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample